Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/20182
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorLIMA, Josenilson F.-
dc.contributor.authorOLIVEIRA, Luanda M. S.-
dc.contributor.authorPEREIRA, Natalli Z.-
dc.contributor.authorDUARTE, Alberto J. S.-
dc.contributor.authorSATO, Maria N.-
dc.date.accessioned2017-06-09T15:37:40Z-
dc.date.available2017-06-09T15:37:40Z-
dc.date.issued2017-
dc.identifier.citationSCIENTIFIC REPORTS, v.7, article ID 524, 9p, 2017-
dc.identifier.issn2045-2322-
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/20182-
dc.description.abstractNatural killer (NK) cells are the main mediator of the cytotoxic response in innate immunity and may be involved in resistance to HIV-1 infection in exposed seronegative (ESN) individuals. Toll-like receptor (TLR) signalling is crucial for NK cell activation. Here, we investigated the polyfunctional NK cell response to TLR3 activation in serodiscordant couples. ESN subjects showed increased IFN-gamma. and CD107a expression in both NK subsets, CD56(bright) and CD56(dim) cells, in response to stimulation with a TLR3 agonist, while expression was impaired in the HIV-1-infected partners. TLR3-induced expression of IFN-gamma, TNF and CD107a by polyfunctional CD56bright NK cells was more pronounced in ESN individuals than that in healthy controls. Activated NK cells, as determined by CD38 expression, were increased only in the HIV-1-infected partners, with reduced IFN-gamma. and CD107a expression. Moreover, CD38(+) NK cells of the HIV-1-infected partners were associated with increased expression of inhibitory molecules, such as NKG2A, PD- 1 and Tim-3, while NK cells from ESN subjects showed decreased NKG2A expression. Altogether, these findings indicate that NK cells of ESN individuals were highly responsive to TLR3 activation and had a polyfunctional NK cell phenotype, while the impaired TLR3 response in HIV-1-infected partners was associated with an inhibitory/ exhaustion NK cell phenotype.-
dc.description.sponsorshipFundacao de Amparo a Pesquisa do Estado de Sao Paulo [2015/00263-7]-
dc.description.sponsorshipLaboratorio de Investigacao Medica, Unidade 56 do Hospital das Clinicas da Faculdade de Medicina de Sao Paulo-
dc.language.isoeng-
dc.publisherNATURE PUBLISHING GROUP-
dc.relation.ispartofScientific Reports-
dc.rightsopenAccess-
dc.subject.otherexposed uninfected individuals-
dc.subject.otherhiv-1 infection-
dc.subject.othert-cells-
dc.subject.otherintegrin alpha(4)beta(7)-
dc.subject.otherantiretroviral therapy-
dc.subject.otherimmune activation-
dc.subject.othernk cells-
dc.subject.otherexpression-
dc.subject.otherresistance-
dc.subject.otherlevel-
dc.titlePolyfunctional natural killer cells with a low activation profile in response to Toll-like receptor 3 activation in HIV-1-exposed seronegative subjects-
dc.typearticle-
dc.rights.holderCopyright NATURE PUBLISHING GROUP-
dc.identifier.doi10.1038/s41598-017-00637-3-
dc.identifier.pmid28373665-
dc.subject.wosMultidisciplinary Sciences-
dc.type.categoryoriginal article-
dc.type.versionpublishedVersion-
hcfmusp.description.articlenumber524-
hcfmusp.description.volume7-
hcfmusp.origemWOS-
hcfmusp.origem.id2-s2.0-85017118586-
hcfmusp.origem.idWOS:000398134800001-
hcfmusp.publisher.cityLONDON-
hcfmusp.publisher.countryENGLAND-
hcfmusp.relation.referenceArthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566-
hcfmusp.relation.referenceAujla SJ, 2009, J MOL MED-JMM, V87, P451, DOI 10.1007/s00109-009-0448-1-
hcfmusp.relation.referenceBegaud E, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-35-
hcfmusp.relation.referenceBenito JM, 2004, AIDS RES HUM RETROV, V20, P227-
hcfmusp.relation.referenceBetts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818-
hcfmusp.relation.referenceBixler S. L., 2013, CLIN DEV IMMUNOL, V2013, DOI 10.1155/2013/852418-
hcfmusp.relation.referenceBrandt L, 2013, JAIDS-J ACQ IMM DEF, V63, P418, DOI 10.1097/QAI.0b013e31828fa22b-
hcfmusp.relation.referenceBrenchley JM, 2008, BLOOD, V112, P2826, DOI 10.1182/blood-2008-05-159301-
hcfmusp.relation.referenceCarrillo J, 2013, AIDS, V27, P1375, DOI 10.1097/QAD.0b013e32835fac08-
hcfmusp.relation.referenceCicala C, 2009, P NATL ACAD SCI USA, V106, P20877, DOI 10.1073/pnas.0911796106-
hcfmusp.relation.referenceClerici M, 2002, AIDS, V16, P1731, DOI 10.1097/00002030-200209060-00004-
hcfmusp.relation.referenceDeeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333-
hcfmusp.relation.referenceDunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8-
hcfmusp.relation.referenceErickson AL, 2008, CLIN VACCINE IMMUNOL, V15, P1745, DOI 10.1128/CVI.00247-08-
hcfmusp.relation.referenceFerre AL, 2009, BLOOD, V113, P3978, DOI 10.1182/blood-2008-10-182709-
hcfmusp.relation.referenceGiorgi JV, 2002, J ACQ IMMUN DEF SYND, V29, P346-
hcfmusp.relation.referenceHO M, 1990, REV INFECT DIS, V12, pS701-
hcfmusp.relation.referenceHorton RE, 2010, J INFECT DIS, V202, pS377, DOI 10.1086/655971-
hcfmusp.relation.referenceHua S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101920-
hcfmusp.relation.referenceJohansson-Lindbom B, 2007, IMMUNOL REV, V215, P226, DOI 10.1111/j.1600-065X.2006.00482.x-
hcfmusp.relation.referenceKim CJ, 2013, J IMMUNOL, V191, P2164, DOI 10.4049/jimmunol.1300829-
hcfmusp.relation.referenceKoning FA, 2005, J IMMUNOL, V175, P6117-
hcfmusp.relation.referenceLederman MM, 2010, J INFECT DIS, V202, pS333, DOI 10.1086/655967-
hcfmusp.relation.referenceLee J, 2011, MOL CELL BIOL, V31, P3963, DOI 10.1128/MCB.05297-11-
hcfmusp.relation.referenceLiang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308-
hcfmusp.relation.referenceLiu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5-
hcfmusp.relation.referenceLiu Y, 2011, IMMUNOLOGY, V132, P540, DOI 10.1111/j.1365-2567.2010.03399.x-
hcfmusp.relation.referenceMcLaren PJ, 2010, J INFECT DIS, V202, pS339, DOI 10.1086/655968-
hcfmusp.relation.referenceMurashev BV, 2012, AIDS RES HUM RETROV, V28, P1598, DOI [10.1089/AID.2011.0335, 10.1089/aid.2011.0335]-
hcfmusp.relation.referenceNdhlovu LC, 2012, BLOOD, V119, P3734, DOI 10.1182/blood-2011-11-392951-
hcfmusp.relation.referencePancino G, 2010, J INFECT DIS, V202, pS345, DOI 10.1086/655973-
hcfmusp.relation.referencePera A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088538-
hcfmusp.relation.referenceRavet S, 2007, BLOOD, V109, P4296, DOI 10.1182/blood-2006-08-040238-
hcfmusp.relation.referenceSchmidt KN, 2004, J IMMUNOL, V172, P138-
hcfmusp.relation.referenceShearer G, 2010, J INFECT DIS, V202, pS329, DOI 10.1086/655974-
hcfmusp.relation.referenceSironi M, 2012, J IMMUNOL, V188, P818, DOI 10.4049/jimmunol.1102179-
hcfmusp.relation.referenceTaborda NA, 2015, AIDS RES HUM RETROV, V31, P636, DOI [10.1089/AID.2014.0325, 10.1089/aid.2014.0325]-
hcfmusp.relation.referenceTrifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770-
hcfmusp.relation.referenceUNAIDS, 2013, GLOB REP GLOB AIDS E-
hcfmusp.relation.referenceVan Braeckel E, 2013, VACCINE, V31, P3739, DOI 10.1016/j.vaccine.2013.05.021-
hcfmusp.relation.referencevan de Weyer Philipp S, 2006, Biochem Biophys Res Commun, V351, P571, DOI 10.1016/j.bbrc.2006.10.079-
hcfmusp.relation.referenceZhang RJ, 2007, AIDS, V21, pS9, DOI 10.1097/01.aids.0000304691.32014.19-
hcfmusp.relation.referenceZhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271-
dc.description.indexMEDLINE-
hcfmusp.citation.scopus20-
hcfmusp.scopus.lastupdate2024-03-29-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MDT
Departamento de Dermatologia - FM/MDT

Artigos e Materiais de Revistas Científicas - FM/MPT
Departamento de Patologia - FM/MPT

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Artigos e Materiais de Revistas Científicas - LIM/56
LIM/56 - Laboratório de Investigação em Dermatologia e Imunodeficiências

Artigos e Materiais de Revistas Científicas - ODS/03
ODS/03 - Saúde e bem-estar


Files in This Item:
File Description SizeFormat 
art_LIMA_Polyfunctional_natural_killer_cells_with_a_low_activation_2017.PDFpublishedVersion (English)2.28 MBAdobe PDFThumbnail
View/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.